In 62 EBVaGC tumour tissues from the SYSUCC cohort, FOS expression was detected to be positively correlated with IGF2BP1/2 expression (Figure 6E), suggesting an underlying positive regulatory mechanism. The gene discussed is FOS; the disease is neoplasm.